• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.血清25(OH)维生素D水平与多发性硬化症患者的残疾无关:一项病例对照研究。
Iran J Neurol. 2015 Jan 5;14(1):17-21.
2
Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症患者季节性血清25-羟基维生素D水平与残疾及复发的相关性
Eur J Clin Nutr. 2016 Sep;70(9):995-9. doi: 10.1038/ejcn.2016.51. Epub 2016 Mar 30.
3
Is serum vitamin D levels associated with disability in patients with newly diagnosed multiple sclerosis?新诊断多发性硬化症患者的血清维生素D水平与残疾有关吗?
Iran J Neurol. 2013;12(2):41-6.
4
Vitamin D and disability in relapsing-remitting multiple sclerosis in patients with a Mexican background.墨西哥裔复发缓解型多发性硬化症患者的维生素D与残疾状况
Acta Neurol Belg. 2018 Mar;118(1):47-52. doi: 10.1007/s13760-017-0834-3. Epub 2017 Oct 3.
5
Vitamin D and body mass index in Egyptian multiple sclerosis patients.埃及多发性硬化症患者的维生素 D 与体重指数。
Mult Scler Relat Disord. 2019 Feb;28:313-316. doi: 10.1016/j.msard.2018.11.035. Epub 2018 Dec 1.
6
Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.维生素D与完全可走动的复发缓解型多发性硬化症患者的残疾程度相关。
Eur J Neurol. 2015 Mar;22(3):564-9. doi: 10.1111/ene.12617. Epub 2014 Dec 20.
7
The association of serum 25-hydroxyvitamin D levels with multiple sclerosis severity and progression in a case-control study from China.在中国一项病例对照研究中血清25-羟维生素D水平与多发性硬化严重程度及进展的关联
J Neuroimmunol. 2016 Aug 15;297:127-31. doi: 10.1016/j.jneuroim.2016.05.022. Epub 2016 May 27.
8
Serum 25-hydroxyvitamin D levels in multiple sclerosis patients from the north of Portugal.葡萄牙北部多发性硬化症患者的血清 25-羟维生素 D 水平。
J Steroid Biochem Mol Biol. 2018 Jun;180:137-141. doi: 10.1016/j.jsbmb.2017.09.016. Epub 2017 Sep 22.
9
Vitamin d3 concentration correlates with the severity of multiple sclerosis.维生素D3浓度与多发性硬化症的严重程度相关。
Int J Prev Med. 2013 May;4(5):585-91.
10
Association of serum 25(OH) vitamin D3 concentration with severity of multiple sclerosis.血清25(OH)维生素D3浓度与多发性硬化严重程度的关联
Iran J Neurol. 2012;11(2):54-8.

引用本文的文献

1
Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis?维生素D用于治疗多发性硬化症是否存在治疗时机窗?
Neural Regen Res. 2022 Sep;17(9):1945-1954. doi: 10.4103/1673-5374.335139.
2
Serum Vitamin D Level among Multiple Sclerosis Patients in the Tropics: Experience from a Private Clinic in Addis Ababa, Ethiopia.热带多发性硬化症患者的血清维生素 D 水平:来自埃塞俄比亚亚的斯亚贝巴一家私人诊所的经验。
Ethiop J Health Sci. 2021 May;31(3):611-618. doi: 10.4314/ejhs.v31i3.18.
3
Vitamin D status and disability among patients with multiple sclerosis: a systematic review and meta-analysis.多发性硬化症患者的维生素D状况与残疾:一项系统评价和荟萃分析。
AIMS Neurosci. 2021 Feb 5;8(2):239-253. doi: 10.3934/Neuroscience.2021013. eCollection 2021.
4
Serum levels of matrix metalloproteinase-2, -9, and vitamin D in patients with multiple sclerosis with or without herpesvirus-6 seropositivity.血清基质金属蛋白酶-2、-9 水平和维生素 D 在多发性硬化症患者与单纯疱疹病毒-6 血清阳性或阴性患者中的差异。
Braz J Infect Dis. 2020 Mar-Apr;24(2):144-149. doi: 10.1016/j.bjid.2020.02.001. Epub 2020 Mar 31.
5
Anti-inflammatory effects of dietary vitamin D in patients with multiple sclerosis.饮食中维生素D对多发性硬化症患者的抗炎作用。
Neurol Genet. 2018 Nov 14;4(6):e278. doi: 10.1212/NXG.0000000000000278. eCollection 2018 Dec.
6
EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.复发缓解型多发性硬化症患者中EB病毒与维生素D状态及独特细胞因子特征
Med Microbiol Immunol. 2016 Apr;205(2):143-54. doi: 10.1007/s00430-015-0437-7. Epub 2015 Sep 13.

本文引用的文献

1
Is serum vitamin D levels associated with disability in patients with newly diagnosed multiple sclerosis?新诊断多发性硬化症患者的血清维生素D水平与残疾有关吗?
Iran J Neurol. 2013;12(2):41-6.
2
Association of serum 25(OH) vitamin D3 concentration with severity of multiple sclerosis.血清25(OH)维生素D3浓度与多发性硬化严重程度的关联
Iran J Neurol. 2012;11(2):54-8.
3
The influence of ethnicity on the characteristics of multiple sclerosis: a local population study between Persians and Arabs.种族对多发性硬化症特征的影响:波斯人和阿拉伯人之间的一项本地人群研究。
Clin Neurol Neurosurg. 2013 Aug;115(8):1271-5. doi: 10.1016/j.clineuro.2012.11.027. Epub 2012 Dec 27.
4
Incidence and prevalence of multiple sclerosis in southeastern Iran.伊朗东南部多发性硬化症的发病率和患病率
Clin Neurol Neurosurg. 2013 Mar;115(3):304-8. doi: 10.1016/j.clineuro.2012.05.032. Epub 2012 Jun 18.
5
Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.血清维生素 D 水平较低与多发性硬化症的复发风险增加有关。
Neurology. 2012 Jul 17;79(3):261-6. doi: 10.1212/WNL.0b013e31825fdec7. Epub 2012 Jun 13.
6
A Comparative Study of 25 (OH) Vitamin D Serum Levels in Patients with Multiple Sclerosis and Control Group in Isfahan, Iran.伊朗伊斯法罕多发性硬化症患者与对照组血清25(OH)维生素D水平的比较研究
Int J Prev Med. 2010 Summer;1(3):195-201.
7
Vitamin D levels in Swiss multiple sclerosis patients.瑞士多发性硬化症患者的维生素 D 水平。
Swiss Med Wkly. 2011 May 3;141:w13192. doi: 10.4414/smw.2011.13192. eCollection 2011.
8
A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.伊朗德黑兰多发性硬化症的 20 年发病趋势(1989-2008 年)和时点患病率(2009 年 3 月 20 日):一项基于人群的研究。
Neuroepidemiology. 2011;36(3):141-7. doi: 10.1159/000324708. Epub 2011 Apr 20.
9
Prevalence of multiple sclerosis in Dubai, United Arab Emirates.阿联酋迪拜多发性硬化症的流行情况。
Int J Neurosci. 2011 Jul;121(7):393-8. doi: 10.3109/00207454.2011.565893. Epub 2011 Apr 4.
10
Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.伊朗伊斯法罕多发性硬化症发病率和患病率急剧上升。
Mult Scler. 2011 Aug;17(8):1022-7. doi: 10.1177/1352458511401460. Epub 2011 Apr 1.

血清25(OH)维生素D水平与多发性硬化症患者的残疾无关:一项病例对照研究。

Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.

作者信息

Nikanfar Masoud, Taheri-Aghdam Ali Akbar, Yazdani Maria, Shaafi Sheida, Masoudian Nooshin, Akbari Hossein, Youhanaee Parisa, Abbaszadeh Hamzeh

机构信息

Department of Neurology, Neuroscience Research Center, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.

Department of Neurology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Iran J Neurol. 2015 Jan 5;14(1):17-21.

PMID:25874052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4395802/
Abstract

BACKGROUND

It seems that serum vitamin D levels are one of the potential environmental factors affecting the severity of multiple sclerosis (MS). In this study, we aim to evaluate vitamin D levels in MS patients and healthy subjects and assess the relationship between vitamin D level and disability.

METHODS

In this case-control study, 168 rapid relapsing MS patients and 168 matched healthy controls were randomly included in this study. Demographic characteristics and serum vitamin D levels for patients and controls, as well as expanded disability status scale (EDSS), duration of disease and diagnostic lag for patients were evaluated. We followed up patients for 6 months and relapses were recorded.

RESULTS

The mean serum vitamin D levels were 19.16 ± 17.37 inpatients and 25.39 ± 19.67 in controls (P = 0.560). The mean serum vitamin D levels were 12.65 ± 13.3 in patients with relapses and 22.08 ± 18.22 in patients without any relapses (P < 0.001). There was no significant correlation between EDSS score and serum vitamin D levels (r = -0.08, P = 0.280). There was a significant positive correlation between EDSS score and disease duration (r = 0.52, P < 0.001).

CONCLUSION

In conclusion, vitamin D level in patients with MS was significantly lower than the healthy subjects, but no significant relationship was found between vitamin D levels and disability. Our findings did not suggest a protective role for serum vitamin D levels against disability.

摘要

背景

血清维生素D水平似乎是影响多发性硬化症(MS)严重程度的潜在环境因素之一。在本研究中,我们旨在评估MS患者和健康受试者的维生素D水平,并评估维生素D水平与残疾之间的关系。

方法

在这项病例对照研究中,168例快速复发型MS患者和168例匹配的健康对照者被随机纳入本研究。评估了患者和对照者的人口统计学特征、血清维生素D水平,以及患者的扩展残疾状态量表(EDSS)、病程和诊断延迟。我们对患者进行了6个月的随访,并记录复发情况。

结果

患者的血清维生素D平均水平为19.16±17.37,对照者为25.39±19.67(P = 0.560)。复发患者的血清维生素D平均水平为12.65±13.3,无复发患者为22.08±18.22(P < 0.001)。EDSS评分与血清维生素D水平之间无显著相关性(r = -0.08,P = 0.280)。EDSS评分与病程之间存在显著正相关(r = 0.52,P < 0.001)。

结论

总之,MS患者的维生素D水平显著低于健康受试者,但未发现维生素D水平与残疾之间存在显著关系。我们的研究结果并未表明血清维生素D水平对残疾具有保护作用。